4.2 Article

Skin hyperpigmentation following intravenous polymyxin B treatment associated with melanocyte activation and inflammatory process

Related references

Note: Only part of the references are listed.
Letter Oncology

Acquired skin hyperpigmentation following intravenous polymyxin B treatment: a cohort study

Karen P. H. Mattos et al.

PIGMENT CELL & MELANOMA RESEARCH (2016)

Letter Pharmacology & Pharmacy

Head and Neck Hyperpigmentation Probably Associated With Polymyxin B Therapy

Alexandre P. Zavascki et al.

ANNALS OF PHARMACOTHERAPY (2015)

Article Dermatology

Clinicopathological correlation of acquired hyperpigmentary disorders

Anisha B. Patel et al.

INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY (2013)

Article Anatomy & Morphology

Cutaneous innervation of the human face as assessed by skin biopsy

Maria Nolano et al.

JOURNAL OF ANATOMY (2013)

Review Biochemistry & Molecular Biology

Sebaceous gland lipids: friend or foe?

K. R. Smith et al.

JOURNAL OF LIPID RESEARCH (2008)

Letter Immunology

Diffuse cutaneous hyperpigmentation due to tigecycline or polymyxin B

Ryan C. Knueppel et al.

CLINICAL INFECTIOUS DISEASES (2007)

Review Biochemistry & Molecular Biology

Human skin pigmentation: melanocytes modulate skin color in response to stress

Gertrude-E. Costin et al.

FASEB JOURNAL (2007)